PharmaShots Weekly Snapshots (May 13 – May 17, 2024)
This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:
BMS Reports the Updated Data from P-III (CheckMate -73L) Study of Opdivo for Non-Small Cell Lung Cancer
Read More: BMS
HUTCHMED Commences the P-III (RAPHAEL) Study of HMPL-306 for Treating Acute Myeloid Leukemia in China
Read More: HUTCHMED
HUTCHMED Commences the P-II/III Study of Surufatinib Plus Camrelizumab for Pancreatic Ductal Adenocarcinoma
Read More: HUTCHMED
Ocugen Concludes Dosing in Cohort 2 of the P-I/II Study Evaluating OCU410ST for Stargardt Disease
Read More: Ocugen
Roche Reveals Results from the P-I Clinical Evaluation of CT-388 for Treating Obesity and Type 2 Diabetes
Read More: Roche
Eli Lilly Reports Data from Two P-III (QWINT-2 and QWINT-4) Studies of Efsitora for Treating Type 2 Diabetes
Read More: Eli Lilly
BMS Reports Results from the P-III (POETYK PSO) Long-Term Extension Study of Sotyktu for Treating Plaque Psoriasis
Read More: BMS
HUTCHMED Reports the P-III Trial Data and will Highlight Hematological Malignancy Programs at the EHA 2024
Read More: HUTCHMED
Regeneron and Sanofi Report the US FDA’s sBLA Acceptance of Dupixent to Treat Chronic Rhinosinusitis with Nasal Polyposis (CRSWNP)
Read More: Regeneron & Sanofi
Zai Lab’s Augtyro Receives the NMPA’s Approval to Treat Non-Small-Cell Lung Cancer (NSCLC)
Read More: Zai Lab
Merus’ Petosemtamab Receives the US FDA’s Breakthrough Therapy Designation for Head and Neck Squamous Cell Carcinoma
Read More: Meru
Roche Receives the US FDA’s Approval for HPV Self-Collection Solutions for Cervical Cancer
Read More: Roche
The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis
Read More: Dynavax
BMS Reports the US FDA’s Accelerated Approval of Breyanzi for Treating Follicular Lymphoma (FL)
Read More: BMS
Amgen’s Imdelltra (Tarlatamab-dlle) Receives the US FDA’s Approval to Treat Extensive-Stage Small Cell Lung Cancer
Read More: Amgen
Fulcrum Therapeutics Partners with Sanofi to Develop and Commercialize Losmapimod for Facioscapulohumeral Muscular Dystrophy
Read More: Fulcrum Therapeutics & Sanofi
Takeda and AC Immune Collaborate for ACI-24.060 to Treat Alzheimer’s Disease
Read More: Takeda & AC Immune
AbbVie Partners with Gilgamesh Pharmaceuticals to Develop Next-Generation Therapies for Psychiatric Disorders
Read More: AbbVie & Gilgamesh Pharmaceuticals
Sol-Gel Technologies and Beimei Pharma Collaborate to Commercialize Twyneo for Treating Acne Vulgaris
Read More: Sol-Gel Technologies & Beimei Pharma
QIAGEN’s QIAstat-Dx Respiratory Syndromic Testing Panel Gains the US FDA’s Clearance to Diagnose Upper Respiratory Infections
Read More: QIAGEN
Profound Medical’s Contouring Assistant AI Module Gains the US FDA’s Approval for Creating Automated TULSA Treatment Plan
Read More: Profound Medical
Atraverse Medical Reports the US FDA’s Clearance of Hotwire Left Heart Access Device
Read More: Atraverse Medical
Karius Reports the US FDA’s Breakthrough Device Designation for its Karius Test to Diagnose Infectious Disease
Read More: Karius
Johnson & Johnson to Expand its Dermatology Portfolio Through the Acquisition of Proteologix
Read More: Johnson & Johnson
Merck Animal Health to Feature Innovative Solutions Focusing Ruminant Health at the World Buiatrics Congress 2024
Read More: Merck Animal Health
Boehringer Ingelheim Introduces Bultavo 3 Vaccine Against Bluetongue Virus Serotype 3 for Sheep and Cattle
Read More: Boehringer Ingelheim
Ainos to Commence Clinical Trial of Veldona-Based Drugs for Treating Pet Disease
Read More: Ainos
Boehringer Ingelheim Partners with Quallent Pharmaceuticals to Expand the Access of Cyltezo (Biosimilar, Humira)
Read More: Boehringer Ingelheim & Quallent Pharmaceuticals
AstraZeneca Reports Results from the P-III (SUPERNOVA) Study of Sipavibart to Prevent COVID-19 in Immunocompromised Patients
Read More: AstraZeneca
Azitra Highlights Preclinical Results and P-Ib Clinical Design of ATR-12 for Netherton Syndrome at the ASGCT 2024
Read More: Azitra
Related Post:- PharmaShots Weekly Snapshots (May 06 – May 10, 2024)
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
